Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Patel

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|September 10, 2024
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional studyTalha Badar, Ravi Narra, Alice S Mims, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Microbiology Spectrum|February 11, 2025
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assaysMaria D Iglesias-Ussel, Aleah Bowie, Jack G Anderson, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Gastrointestinal Endoscopy|September 23, 2019
EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video)Somashekar G Krishna, Phil A Hart, John M DeWitt, et al.
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026Daniel A Pollyea, Jessica K Altman, Rita Assi, et al.
Blood|July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidenceZhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|September 10, 2024
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional studyTalha Badar, Ravi Narra, Alice S Mims, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Microbiology Spectrum|February 11, 2025
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assaysMaria D Iglesias-Ussel, Aleah Bowie, Jack G Anderson, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Gastrointestinal Endoscopy|September 23, 2019
EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video)Somashekar G Krishna, Phil A Hart, John M DeWitt, et al.
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026Daniel A Pollyea, Jessica K Altman, Rita Assi, et al.
Blood|July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidenceZhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Pageof 15